Ingredient
Ethyl Perfluorobutyl Ether
Ethyl Perfluorobutyl Ether is flagged for pregnancy and breastfeeding. The concern behind the strongest flag is absorbed into the body and fetal development.
- Perfluorobutyl Ethyl Ether
- PFBE
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 2 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Ethyl Perfluorobutyl Ether and pregnancy
Caution Advised
- Absorbed into the body
- Fetal development
Ethyl perfluorobutyl ether is a per- and polyfluoroalkyl substance (PFAS), part of a family of synthetic chemicals that persist in the environment and body. In cosmetics, it functions as a solvent that helps other ingredients penetrate the skin and creates a smooth product texture. Studies on PFAS chemicals have shown they can cross the placental barrier and have been detected in cord blood. While longer-chain PFAS like PFOA and PFOS have documented links to adverse pregnancy outcomes including reduced birth weight and developmental effects, shorter-chain PFAS like perfluorobutyl compounds have less research. However, the EPA and ATSDR note that all PFAS share concerning properties: they bioaccumulate, resist breakdown, and have potential for developmental toxicity. Many dermatologists and environmental health experts recommend pregnant women minimize exposure to PFAS chemicals when possible, following a precautionary approach. While this specific short-chain PFAS may be less toxic than its long-chain relatives, the lack of comprehensive safety data during pregnancy and the general concerns about PFAS bioaccumulation suggest choosing PFAS-free alternatives when available.
Ethyl Perfluorobutyl Ether and breastfeeding
Caution Advised
- Passes into breast milk
- Infant exposure
Ethyl perfluorobutyl ether is a PFAS chemical, and PFAS compounds are known to transfer into breast milk. Studies by the CDC and various research institutions have detected PFAS chemicals in breast milk samples, raising concerns about infant exposure during the breastfeeding period. While this shorter-chain PFAS may have different bioaccumulation properties than well-studied long-chain PFAS, the general tendency of fluorinated compounds to accumulate in fatty tissues and transfer to milk is concerning. Research on PFAS and breastfeeding shows these chemicals can persist in the body for years and be passed to breastfed infants, though health effects in infants are still being studied. The AAD and environmental health organizations suggest that breastfeeding mothers minimize exposure to PFAS when practical alternatives exist. While the benefits of breastfeeding generally outweigh concerns about environmental chemical exposure, choosing PFAS-free cosmetics is a reasonable precautionary measure to reduce infant chemical burden.
Ethyl Perfluorobutyl Ether and postpartum
Safe to Use
For postpartum women who are not breastfeeding, ethyl perfluorobutyl ether presents lower immediate concerns, as there's no risk of transferring the chemical to an infant through milk. The ingredient functions as a solvent and is generally well-tolerated on skin with minimal irritation. However, PFAS chemicals are persistent and bioaccumulate over time, so minimizing exposure remains prudent for long-term health. For postpartum recovery and skin concerns, many effective alternatives exist that don't carry the environmental and bioaccumulation concerns associated with PFAS compounds.
Ethyl Perfluorobutyl Ether and trying to conceive
Safe to Use
For women trying to conceive, ethyl perfluorobutyl ether doesn't have documented effects on fertility or conception. While some longer-chain PFAS chemicals have been associated with reduced fertility in epidemiological studies, the evidence for shorter-chain PFAS like this perfluorobutyl compound is insufficient to draw conclusions. The general recommendation to minimize chemical exposures when trying to conceive could include avoiding PFAS compounds as a precautionary measure, but there's no specific evidence this ingredient affects conception. Once pregnant, more caution is warranted due to concerns about placental transfer.
Ethyl Perfluorobutyl Ether and PCOS
Safe to Use
Ethyl perfluorobutyl ether does not have known direct hormonal effects relevant to PCOS management. It functions as a solvent in cosmetic formulations and doesn't interfere with androgen or insulin pathways that are central to PCOS. While some longer-chain PFAS have shown potential endocrine-disrupting properties in research studies, evidence for shorter-chain PFAS like perfluorobutyl compounds affecting hormones is limited. For women with PCOS, this ingredient is unlikely to impact their hormonal balance or metabolic concerns. From a PCOS perspective, this ingredient is relatively neutral. The main consideration would be the general preference to minimize exposure to persistent chemicals, but there's no specific mechanism by which this PFAS would worsen PCOS symptoms or interfere with treatment.
Ethyl Perfluorobutyl Ether and general use
Safe to Use
- Environmental pollutant
Ethyl perfluorobutyl ether is a shorter-chain PFAS used as a solvent in cosmetic formulations. For the general public, it presents minimal acute health risks and is generally non-irritating when applied topically. It helps products spread smoothly and can enhance the delivery of other ingredients. The primary concern with this ingredient relates to its environmental persistence and potential for bioaccumulation rather than immediate toxicity. PFAS chemicals don't break down naturally and can accumulate in the body over time with repeated exposure. The ECHA and various environmental agencies are increasingly scrutinizing PFAS in consumer products due to these persistence concerns. For most users, short-term exposure to this ingredient in cosmetics is unlikely to cause adverse effects. However, from an environmental and long-term health perspective, many consumers choose to avoid PFAS-containing products when alternatives are available. The cosmetic industry is gradually moving away from PFAS chemicals in response to regulatory pressure and consumer preferences.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Ethyl Perfluorobutyl Ether, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store